ProCE Banner Activity

From IAS COVID-19 Prevention: Significant Advances in a Global Vaccination Program

Conference Coverage
Clinical Thought
Advances in vaccine technologies and trials are leading to robust data for global vaccination efforts. Current vaccines have varying degrees of efficacy, and emerging variants are creating further deviation, suggesting a need for a rapid increase in vaccinations as well as improved molecular surveillance.

Released: March 18, 2021

Expiration: March 17, 2022

Share

Faculty

Kenneth Mayer

Kenneth Mayer, MD

Infectious Disease Attending
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Medical Research Director
Fenway Community Health
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc.

Partners

IAS 2018

ProCE Banner

IAS COVID

ProCE Banner

Faculty Disclosure

Primary Author

Kenneth Mayer, MD

Infectious Disease Attending
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Medical Research Director
Fenway Community Health
Boston, Massachusetts

Kenneth Mayer, MD, has disclosed that he has received funds for research support from Gilead Sciences, Janssen, and Merck and consulting fees from Gilead Sciences and Merck.